Nicholas N. Vahanian
No más puestos en curso
Historial de carrera de Nicholas N. Vahanian
Antiguos cargos conocidos de Nicholas N. Vahanian.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LUMOS PHARMA, INC. | Director/Miembro de la Junta | 13/11/2015 | 11/11/2019 |
| Director de Operaciones | 01/01/2001 | 21/12/2013 | |
| Director Técnico/Científico/I+D | 01/01/2001 | 13/11/2017 | |
| Fundador | 04/06/1999 | 11/11/2019 | |
| Presidente | 01/01/2009 | - | |
| LUMOS PHARMA, INC. | Presidente | - | 27/09/2019 |
Formación de Nicholas N. Vahanian.
| Virginia Commonwealth University | Undergraduate Degree |
| University of Notre Dame | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| President | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LUMOS PHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
- Bolsa de valores
- Insiders
- Nicholas N. Vahanian
- Experiencia
